New nets data presented at international society on thrombosis and haemostasis (isth) congress

Henderson, nev. , july 13, 2022 /prnewswire/ -- volitionrx limited (nyse american: vnrx) ("volition"), a multi-national epigenetics company, in collaboration with researchers at the university of namur and qualiblood in belgium has published a poster presentation entitled "evaluation and comparison of netosis biomarkers in sepsis and covid-19 patients"  at the international society on thrombosis and haemostasis (isth) congress earlier this week.
VNRX Ratings Summary
VNRX Quant Ranking